Parenterale Goldtherapie bei rheumatoider Arthritis – pro

rheumatoide Arthritis - Goldtherapie

rheumatoid arthritis - gold therapy

Literatur

• 1 Lehman A J. et al . A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis.  Arthritis Rheum. 2005;  52 1360-1370
• 2 Myllykangas-Luosujärvi R. et al . Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died.  J Rheumatol. 1995;  22 2214-2217
• 3 Rau R. et al . Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis.  Br J Rheumatol. 1997;  36 345-352
• 4 Sander O. et al . Prospective 6-year follow up of patients withdrawn from a randomised study comparing parenteral gold and methotrexate.  Ann Rheum Dis. 1999;  58 281-287
• 5 Smolen J S. et al . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.  Ann Rheum Dis. 2010;  69 964-975